Details for Patent: 5,384,113
✉ Email this page to a colleague
Summary for Patent: 5,384,113
Title: | Stabilizers to prevent autoradiolysis of radiolabeled peptides and proteins |
Abstract: | Gentisic acid and its derivatives substantially inhibit peptide autoradiolysis. Gentisic acid or its derivatives may also be used in combination with other stabilizers such as inositol and ascorbic acid to inhibit autoradiolysis of radiolabeled peptides. |
Inventor(s): | Deutsch; Edward A. (Maryland Heights, MO), Goedemans; Wilhelmus T. (Bergen, NL), Maria de Jong; Martinus T. (Hoogkarspel, NL), Miller; Kathleen M. (St. Louis, MO), Brodack; James W. (Florissant, MO) |
Assignee: | Mallinckrodt Medical, Inc. (St. Louis, MO) |
Application Number: | 08/135,882 |
Patent Claim Types: see list of patent claims | Use; Composition; Device; Formulation; |
Drugs Protected by US Patent 5,384,113
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,384,113
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 196428 | ⤷ Sign Up | |||
Australia | 2462592 | ⤷ Sign Up | |||
Canada | 2113995 | ⤷ Sign Up | |||
Germany | 69231469 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |